Faron Announces Positive FDA Feedback | 11-Jul-2024 | 07:00 | RNS |
Update on settlement | 25-Jun-2024 | 14:00 | RNS |
Holding(s) in Company - Replacement | 25-Jun-2024 | 10:30 | RNS |
Holding(s) in Company | 24-Jun-2024 | 12:45 | RNS |
Holding(s) in Company | 24-Jun-2024 | 12:45 | RNS |
Holding(s) in Company | 24-Jun-2024 | 12:45 | RNS |
Holding(s) in Company | 24-Jun-2024 | 12:45 | RNS |
New shares registered with Finnish Trade Register | 20-Jun-2024 | 13:00 | RNS |
Fully subscribed EUR 30.7 million share offering | 20-Jun-2024 | 07:00 | RNS |
Proposed REX Retail Offer | 05-Jun-2024 | 08:00 | RNS |
Faron commences a share offering | 04-Jun-2024 | 07:00 | RNS |
Initial positive data from Phase 2 of BEXMAB | 20-May-2024 | 07:00 | RNS |
Issuance of warrants | 17-May-2024 | 16:00 | RNS |
Replacement – Board Change | 13-May-2024 | 07:00 | RNS |
Update on financial status | 30-Apr-2024 | 14:00 | RNS |
Currency | UK Pounds |
Share Price | 152.50p |
Change Today | 5.50p |
% Change | 3.74 % |
52 Week High | 350.00p |
52 Week Low | 92.50p |
Volume | 100,377 |
Shares Issued | 104.62m |
Market Cap | £159.55m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 1 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
15:32 | 9,530 @ 152.10p |
16:25 | 3,290 @ 152.13p |
16:23 | 3,076 @ 152.13p |
16:18 | 451 @ 155.00p |
16:15 | 981 @ 155.00p |
CEO | Juho Jalkanen |
Chair | Tuomo Pätsi |
You are here: research